New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:10 EDTMBII, EVGNEvogene, Marrone Bio sign multi-year collaborative agreement
Evogene (EVGN) and Marrone Bio Innovations (MBII) announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field. The companies will utilize the collaboration's joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while MBI will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration
News For EVGN;MBII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
08:39 EDTMBIIMarrone Bio REGALIA MAXX biofungicide approved for new uses in Canada
Marrone Bio announced that its REGALIA MAXX biofungicide has received approval for new uses in Canada. REGALIA MAXX is a plant extract-based advanced biofungicide that activates plants' natural defenses to boost plant vigor, combat fungal and bacterial diseases, and enhance yield potential. The recently approved new uses for REGALIA MAXX in Canada include outdoor and greenhouse grown ornamental plants, annual and perennial flower plants, greenhouse grown peppers, and outdoor grown highbush blueberries, apples and turf. Health Canada's Pest Management Regulatory Agency initially approved REGALIA MAXX biofungicide in April 2012 for outdoor and greenhouse use on a variety of fruits and vegetables, as well as on wheat and ornamentals.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use